BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34080256)

  • 1. Exceeding 30 ELNs is strongly recommended for pT3-4N0 patients with gastric cancer: A multicenter study of survival, recurrence, and prediction model.
    Zhao L; Han W; Yang X; Zhao D; Niu P; Gao X; Wu Z; Zhang X; Li Z; Ji G; Chen Y
    Cancer Sci; 2021 Aug; 112(8):3266-3277. PubMed ID: 34080256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.
    Jiao XG; Deng JY; Zhang RP; Wu LL; Wang L; Liu HG; Hao XS; Liang H
    World J Gastroenterol; 2014 Apr; 20(13):3640-8. PubMed ID: 24707149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes.
    Huang JY; Xing YN; Wang X; Wang ZN; Hou WB; Yin SC; Xu YY; Zhu Z; Xu HM
    J Gastrointest Surg; 2020 Feb; 24(2):299-306. PubMed ID: 30671803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
    BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.
    Zhang N; Bai H; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
    Ann Transl Med; 2020 Sep; 8(17):1075. PubMed ID: 33145294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study.
    MingHua Z; KeCheng Z; ZhenYu C; Lin C; ChunXi W; ZeLong Y
    J Gastrointest Surg; 2021 Apr; 25(4):919-925. PubMed ID: 32318943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pN classification system.
    Yin K; Jin X; Pan Y; Zi M; Zheng Y; Ma Y; Pang C; Liu K; Chen J; Wei Y; Liu D; Cheng X; Yuan L
    J Gastrointest Surg; 2024 May; ():. PubMed ID: 38821213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
    Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
    Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined.
    Wang PL; Xiao FT; Gong BC; Liu FN; Xu HM
    J Gastrointest Surg; 2017 Jun; 21(6):947-956. PubMed ID: 28349332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
    Yuan SQ; Chen YT; Huang ZP
    J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.
    Chen C; Shen J; Xing Z; Jiang C; Hu L; Cui L; Xue D; He X; Xu R
    Int Urol Nephrol; 2020 Feb; 52(2):271-278. PubMed ID: 31571158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minimum number of examined lymph nodes for accurate nodal staging and optimal survival of stage T1-2 esophageal squamous cell carcinoma: A retrospective multicenter cohort with SEER database validation.
    Tian D; Li HX; Yang YS; Yan HJ; Jiang KY; Zheng YB; Zong ZD; Zhang HL; Guo XG; Wen HY; Chen LQ
    Int J Surg; 2022 Aug; 104():106764. PubMed ID: 35803513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of anatomical extent of metastatic lymph node on gastric cancer: a propensity score matching study.
    Cheng LJ; Zhou WJ; An TL; Wei ZW; Yuan C; Xiao X; Hao TF; Yin SC; Zhang CH; He YL
    Clin Transl Oncol; 2021 Apr; 23(4):773-782. PubMed ID: 32772226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis.
    Yang H; Fang Z; Liu T; Zhu X; Luo L
    Aging Clin Exp Res; 2023 Jan; 35(1):203-212. PubMed ID: 36319940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
    Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Removal of Lymph Nodes on Survival in Stage I-III Gastric Signet-Ring Cell Cancer: The More, the Better?
    Jiang Y; Shao X; Li W; Hu H; Lu Y; Li Y; Tian Y
    Ann Surg Oncol; 2024 Feb; 31(2):783-791. PubMed ID: 37991582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.